Laura Gregg is a Rheumatology/Immunology physician. OpenAlex indexes 7 publications with 212 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4901 Lang Ave NE
Albuquerque, NM 871094397
Telephone
505-842-8171Provider last certified this registry record 4 Sept 2024.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202531 payments
- Amgen Inc.Program year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
28.3%Folate Analog Metabolic Inhibitor11.3%Methotrexate100%Part D≥20 patientsTNF inhibitor5.4%Humira(Cf) Pen100%Part D<11 patients+ 3 more classes in this area
Antiparasitic
27.7%Antimalarial27.7%Hydroxychloroquine Sulfate100%Part D≥51 patientsMetabolism & gastrointestinal
26.1%Corticosteroid16.6%Prednisone100%Part D≥39 patientsAminosalicylate5.6%Sulfasalazine Dr100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function
Behavioural Brain Research
2015 - Activation of group III metabotropic glutamate receptors regulates stress-induced analgesia through an endocannabinoid mechanism2010
- Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
European Journal of Neuroscience
2009
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”